Brief: Poly Medicure Says No Major Adverse Impact Of COVID-19 On Co's Business Ops
May 22 (Reuters) - Poly Medicure Ltd PLMD.NS :
* THERE IS NO MAJOR ADVERSE IMPACT OF COVID-19 ON CO'S
BUSINESS
OPERATIONS
Source text: https://bit.ly/2zWGaRY
Further company coverage: PLMD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Poly Medicure
See all newsBrief: Poly Medicure Ltd Q2 consol net profit 951.3 million rupees
Brief: Poly Medicure June-Quarter Consol Net Profit 860.3 Million Rupees
Brief: Poly Medicure March-Quarter Consol Net Profit 662.9 Million Rupees
Brief: Poly Medicure Says Unit Buys 100% Equity In Medyneo
Brief: Poly Medicure Ltd Says Polymed Brazil Lida To Buy 100% Equity In Medyneo